A double-blinded placebo-controlled pilot trial of calcium alumina-silicate (CASAD) in the treatment of severe diarrhea (grade 3 or 4) in cancer patients presenting for emergency care.
Phase of Trial: Phase II
Latest Information Update: 02 Aug 2018
Price : $35 *
At a glance
- Drugs Calcium aluminium silicate (Primary)
- Indications Diarrhoea
- Focus Therapeutic Use
- 19 Aug 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 20 Dec 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT02018653).
- 20 Dec 2013 Planned end date 1 Dec 2015 added as reported by ClinicalTrials.gov.